The CXCR4 Antagonist AMD3100 Has Dual Effects, Initially Enhancing and Later Inhibiting Survival and Proliferation, in Myeloid Leukemia Cells in Vitro.

被引：0
|
作者：
Kim, Ha-Yon [1 ]
Hwang, Ji-Young [1 ]
Kim, Seong-Woo [1 ]
Yun, Gak-Won [1 ]
Yang, Young-Joon [1 ]
Lee, Hyo-Jin [1 ]
Jo, Deog-Yeon [1 ,2 ]
机构：
[1] Chungnam Natl Univ, Dept Internal Med, Sch Med, Div Hematol Oncol, Taejon, South Korea
[2] Chungnam Natl Univ, Canc Res Inst, Taejon, South Korea
来源：
BLOOD | 2009年 / 114卷 / 22期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：685 / 686
页数：2
相关论文
共 50 条
  • [1] The CXCR4 Antagonist AMD3100 Has Dual Effects on Survival and Proliferation of Myeloma Cells In Vitro
    Kim, Ha-Yon
    Hwang, Ji-Young
    Kim, Seong-Woo
    Lee, Hyo-Jin
    Yun, Hwan-Jung
    Kim, Samyong
    Jo, Deog-Yeon
    CANCER RESEARCH AND TREATMENT, 2010, 42 (04): : 225 - 234
  • [2] The CXCR4 antagonist AMD3100 stimulates the proliferation of myeloma cells
    Kim, H. Y.
    Kim, S. W.
    Lee, H. J.
    Yun, H. J.
    Kim, S.
    Jo, D. Y.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S178 - S178
  • [3] The CXCR4 Antagonist AMD3100 Stimulates the Proliferation of Myeloma Cells
    Kim, Ha-Yon
    Kim, Seong-Woo
    Lee, Hyo-Jin
    Yun, Hwan-Jung
    Kim, Samyong
    Jo, Deog-Yeon
    BLOOD, 2008, 112 (11) : 600 - 601
  • [4] Chemosensitization of acute myeloid leukemia (AML) following mobilization by the CXCR4 antagonist AMD3100
    Nervi, Bruno
    Ramirez, Pablo
    Rettig, Michael P.
    Uy, Geoffrey L.
    Holt, Matthew S.
    Ritchey, Julie K.
    Prior, Julie L.
    Piwnica-Worms, David
    Bridger, Gary
    Ley, Timothy J.
    DiPersio, John F.
    BLOOD, 2009, 113 (24) : 6206 - 6214
  • [5] The CXCR4 Antagonist AMD3100 Impairs Survival of AML Cells and Induces Their Differentiation
    Tavor, Sigal
    Eisenbach, Manny
    Jacob-Hirsch, Jasmine
    Golan, Tammar
    Petit, Isabelle
    Ben-Zion, Katz
    Kay, Sigi
    Baron, Shoshana
    Amariglio, Ninette
    Deutsch, Varda
    Naparstek, Elizabeth
    Rechavi, Gideon
    BLOOD, 2008, 112 (11) : 573 - 573
  • [6] The CXCR4 antagonist AMD3100 impairs survival of human AML cells and induces their differentiation
    Tavor, S.
    Eisenbach, M.
    Jacob-Hirsch, J.
    Golan, T.
    Petit, I.
    BenZion, K.
    Kay, S.
    Baron, S.
    Amariglio, N.
    Deutsch, V.
    Naparstek, E.
    Rechavi, G.
    LEUKEMIA, 2008, 22 (12) : 2151 - 2158
  • [7] The CXCR4 antagonist AMD3100 impairs survival of human AML cells and induces their differentiation
    S Tavor
    M Eisenbach
    J Jacob-Hirsch
    T Golan
    I Petit
    K BenZion
    S Kay
    S Baron
    N Amariglio
    V Deutsch
    E Naparstek
    G Rechavi
    Leukemia, 2008, 22 : 2151 - 2158
  • [8] Effect of the CXCR4 antagonist, AMD3100, on retinal pigment epithelial cells
    Clark, A. E.
    Aungier, S.
    Moir, G.
    Crane, I. J.
    IMMUNOLOGY, 2010, 131 : 96 - 96
  • [9] Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist
    Liles, WC
    Broxmeyer, HE
    Rodger, E
    Wood, B
    Hübel, K
    Cooper, S
    Hangoc, G
    Bridger, GJ
    Henson, GW
    Calandra, G
    Dale, DC
    BLOOD, 2003, 102 (08) : 2728 - 2730
  • [10] The CXCR4 antagonist Plerixafor (AMD3100) promotes Ewing sarcoma cell survival and migration in Ewing sarcoma cells in vitro
    Dirksen, U.
    Berning, P.
    Schaefer, C.
    Potratz, J.
    EUROPEAN JOURNAL OF CANCER, 2016, 69 : S50 - S50
12345